Supreme Court Rules For Big Pharma In Integra v. Merck

Law360, New York (June 13, 2005, 12:00 AM EDT) -- In a landmark decision with broad implications for the pharmaceutical industry, the U.S. Supreme Court has ruled that drug makers can ignore their competitors' patents during research on rival treatments.

In a unanimous decision, the nation’s highest court set aside a ruling by the U.S. Court of Appeals for the Federal Circuit in favor of patent holder Integra LifeSciences Holdings Corp. in a patent dispute with drug maker Merck KGaA of Germany.

The Court agrees with the government that “the use of patented compounds in preclinical...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.